Tata Sons Chairman admits that Air India's response to a drunk man urinating on a woman could have been swifter.  Unsplash
MedBound Blog

Tata Sons Chairman Admits that Air India Fell Short to Address the Issue of Man Urinating on a Woman

Natarajan Chandrasekaran, Chairperson of the Tata Group, further added that the airline fell short to address the situation.

Dr. Amey Patil

Tata Sons Chairman admits that Air India's response to a drunk man urinating on a woman could have been swifter.

Natarajan Chandrasekaran, Chairperson of the Tata Group, further added that the airline fell short to address the situation.

Shankar Mishra, in an inebriated state, unzipped his pants and urinated on an elderly woman on November 26. Air India didn't file a complaint immediately saying there was no further flare-up of the issue. They had banned the passenger from flying for 30 days.

The woman faced a lot of difficulties on board as well. She was asked to go back to her dirty seat despite the flight having many empty seats. Air India filed a complaint six weeks later on January 4.

Air India CEO Campbell Wilson apologized for the incident as well. He said that the four cabin crew staff and the pilot have been fired. He further added that the company is reviewing its policy on the service of alcohol in flight.

Mr. Chandrasekaran claimed that Air India stands behind the safety of their passengers. He added that they will review and repair every process to make sure that incidents like these do not happen in the future.

Air India CEO Campbell Wilson apologized for the incident as well. He said that the four cabin crew staff and the pilot have been fired. He further added that the company is reviewing its policy on the service of alcohol in flight.

(Input from various media sources)

India’s Triumph Over Polio: A Public Health Milestone

GTB Doctor Urges CAQM to Exempt Vehicles for People with Disabilities

When Stress Hijacks Your Memories, Why Safe Feels Scary!

Severe COVID-19 Infection May Lead to Tumor Shrinkage, New Study Finds

First mRNA Norovirus Vaccine Enters Trial to Combat Global Health Crisis